Tumor formation is correlated with expression of β-catenin-accumulated crypts in azoxymethane-induced colon carcinogenesis in mice

被引:27
作者
Hata, K
Yamada, Y
Kuno, T
Hirose, Y
Hara, A
Qiang, SH
Mori, H
机构
[1] Gifu Univ, Sch Med, Dept Pathol, Gifu 5008705, Japan
[2] Sunplanet Co Ltd, BMR Labs, Gifu 5031602, Japan
来源
CANCER SCIENCE | 2004年 / 95卷 / 04期
关键词
D O I
10.1111/j.1349-7006.2004.tb03209.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have reported that beta-catenin-accumulated crypts (BCAC) are independent of aberrant crypt foci (ACF) in the colonic mucosa of rats exposed to colorectal carcinogens, and we suggested that they may be premalignant lesions. In the present study, we performed a comparative study on the formation of the two types of early-appearing lesions (BCAC and ACF), and tumors of the colon in two mouse strains with different susceptibility to azoxymethane (AOM). SWR/J mice are known to be relatively susceptible to AOM, whereas AKR/J mice are reported to be virtually resistant. Both AKR/J and SWR/J mice, 6 weeks old, received subcutaneous injections of AOM (15 mg/kg body weight) once a week for 3 weeks, and were sacrificed at 16 and 41 weeks of age. Colons of the animals sacrificed at 16 and 41 weeks of age were processed to examine expression of the early-appearing lesions and neoplasms. Although AKR/J mice had a lower incidence of colonic tumors than SWR/J mice did, AKR/J mice showed a similar frequency of ACF to that in SWR/J mice. In both strains, ACF were detected at high frequency in the proximal colon, whereas tumors developed mainly in the distal colon. Importantly, the incidence of BCAC in SWR/J mice was significantly higher than that in AKR/J mice, and the highest frequency was observed in the distal segments of the colon. These results support the idea that BCAC are a reliable surrogate endpoint for colon carcinogenesis in mice.
引用
收藏
页码:316 / 320
页数:5
相关论文
共 30 条
[1]   beta-catenin is a target for the ubiquitin-proteasome pathway [J].
Aberle, H ;
Bauer, A ;
Stappert, J ;
Kispert, A ;
Kemler, R .
EMBO JOURNAL, 1997, 16 (13) :3797-3804
[2]   OBSERVATION AND QUANTIFICATION OF ABERRANT CRYPTS IN THE MURINE COLON TREATED WITH A COLON CARCINOGEN - PRELIMINARY FINDINGS [J].
BIRD, RP .
CANCER LETTERS, 1987, 37 (02) :147-151
[3]  
BIRD RP, 1989, CANCER SURV, V8, P189
[4]   ROLE OF ABERRANT CRYPT FOCI IN UNDERSTANDING THE PATHOGENESIS OF COLON-CANCER [J].
BIRD, RP .
CANCER LETTERS, 1995, 93 (01) :55-71
[5]   Identification of c-MYC as a target of the APC pathway [J].
He, TC ;
Sparks, AB ;
Rago, C ;
Hermeking, H ;
Zawel, L ;
da Costa, LT ;
Morin, PJ ;
Vogelstein, B ;
Kinzler, KW .
SCIENCE, 1998, 281 (5382) :1509-1512
[6]   Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis [J].
Hirose, Y ;
Kuno, T ;
Yamada, Y ;
Sakata, K ;
Katayama, M ;
Yoshida, K ;
Qiao, Z ;
Hata, K ;
Yoshimi, N ;
Mori, H .
CARCINOGENESIS, 2003, 24 (01) :107-111
[7]   Induction of apoptosis by sulindac in azoxymethane-induced possible colonic premalignant lesions in rats [J].
Kuno, T ;
Yamada, Y ;
Hirose, Y ;
Katayama, M ;
Sakata, K ;
Hara, A ;
Saji, S ;
Mori, H .
JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (03) :242-246
[8]  
Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229
[9]   Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC [J].
Morin, PJ ;
Sparks, AB ;
Korinek, V ;
Barker, N ;
Clevers, H ;
Vogelstein, B ;
Kinzler, KW .
SCIENCE, 1997, 275 (5307) :1787-1790
[10]   Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine [J].
Ochiai, M ;
Ushigome, M ;
Fujiwara, K ;
Ubagai, T ;
Kawamori, T ;
Sugimura, T ;
Nagao, M ;
Nakagama, H .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (04) :1607-1614